NCT01304849
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +7 more
- Locations
-
- Department of Medical Oncology, Cancer Institute (WIA), Adyar Chennai, Tamil Nadu, India
Clinical trial condition
Hodgkin's Lymphoma
Explore clinical trials studying Hodgkin's Lymphoma. Study availability and eligibility vary by location and protocol.
66 public trials
5 recruiting studies
Hodgkin's Lymphoma trial results
NCT00791011
- Conditions
- Diffuse Large Cell Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +15 more
- Locations
-
Not specified
NCT01037478
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +7 more
- Locations
-
- Fakultní nemocnice Brno Brno, Czechia
- Fakultní nemocnice Hradec Kralové Hradec Kralové, Czechia
- Fakultní nemocnice Kralovske Vinohrady Prague, Czechia
- Uniwersyteckie Centrum Kliniczne Gdansk, Poland
NCT01402687
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Digestive System Diseases, +24 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT01478191
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +7 more
- Locations
-
- Istituto Oncologico del Mediterraneo Catania, Italy
- Policlinico Maggiore Milan, Italy
- Ospedale San Gennaro Naples, Italy
- Azienda Ospedaliera V. Cervello Palermo, Italy
NCT00887718
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +9 more
- Locations
-
- University Health Network, Princess Margaret Hospital Toronto, Ontario, Canada
Completed
Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in the Treatment of Hodgkin's Lymphoma
NCT00359892
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +7 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
NCT00741871
- Conditions
- B Cell Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +12 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Completed
CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation
NCT00333190
- Conditions
- ALL, AML, Blood Protein Disorders, +24 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT00273936
- Conditions
- Acute Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +22 more
- Locations
-
- Arizona Clinical Research Center Tucson, Arizona, United States
- Stanford Cancer Center Stanford, California, United States
- George Washington University Washington D.C., District of Columbia, United States
- Ohio State University, James Cancer Hospital Comprehensive Cancer Center Columbus, Ohio, United States